Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A systematic program to test incarcerated Americans for hepatitis C and treat those who are infected would be highly cost-effective.
The Centers for Disease Control and Prevention?s (CDC) monitoring of acute, or very early, hepatitis C cases is woefully inadequate.
In most cases, Harvoni is cost effective when compared with older hepatitis C treatments, but treating all of those in need will be highly exp...
Sovaldi (sofosbuvir) is a cost-effective treatment option for hepatitis C among the prison population when compared with other options.
Thanks to new, highly effective treatments and increased screening, hepatitis C could become a rare disease in 22 years, according to a modeli...
Experts also called into question how many people would actually have access to new, expensive life-saving therapies.
The U.S. Preventive Services Task Force has recommended screening for those at high risk of hepatitis B infection, including those with HIV.
Reducing its estimate of hepatitis C prevalence from 3.2 to 2.7 million, the CDC calculated that four in five cases are among baby boomers.
Fibrosis in those coinfected with HCV and HIV is comparable in severity to that found in people mono- infected with hep C a decade older.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.